General
Preferred name
framycetin
Synonyms
Vibrocil ()
Tribiotic ()
Cicatrin ()
Biomydrin ()
Naseptin ()
Myciguent ()
Cicatrene ()
Graneodin ()
Neosporin ()
Nivemycin ()
Neobacrin ()
Gppe Nsl Gel ()
neomycin ()
Neomycin Sulphate B ()
Framycetin sulphate ()
Framycin sulfate ()
NEOMYCIN SULFATE ()
Framycetin (sulfate) ()
Framycetin sulfate ()
Neomycin B (sulfate) ()
Fradiomycin B (sulfate) ()
ANTIBIOTIQUE EF 185 ()
Framygen ()
Actilin ()
Antibiotic 10676 ()
Dekamycin iii ()
Neomycin B ()
Framycetine ()
Enterfram ()
Framidal ()
Framycin ()
Francetin ()
Framicetina ()
Fradiomycin B ()
Neomycin (sulfate) ()
P&D ID
PD009601
CAS
28002-70-2
1405-10-3
11025-81-3
119-04-0
4146-30-9
Tags
available
biased GPCR ligand
drug
natural product
Drug indication
Alcoholic cirrhosis of liver
Acute liver failure
Bacterial infection
Nasal congestion
Drug Status
approved
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
32
DESCRIPTION
Neomycin is an aminoglycoside antibacterial. Neomycin is active against Gram-negative bacteria, and partially active against Gram-positive bacteria. Standard grade neomycin is a mixture of several related compounds, including neomycin A (neamine), neomycin B (framycetin) and neomycin C, with neomycin B being the most active component. We show the structure of neomycin B here.
(GtoPdb)
DESCRIPTION
Framycetin sulfate (Neomycin Sulphate B) belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Neomycin sulfate (Framycin sulfate) is a broad-spectrum aminoglycoside antibiotic that blocks the synthesis of bacterial proteins in order to exert antimicrobial activity. Neomycin sulfate is commonly used to screen prokaryotic and eukaryotic cells for Neo resistance genes.
(TargetMol Bioactive Compound Library)
DESCRIPTION
Framycetin is an aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
18
BiasDB
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine Bioactive Compounds
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
90
Molecular Weight
614.31
Hydrogen Bond Acceptors
19
Hydrogen Bond Donors
13
Rotatable Bonds
9
Ring Count
4
Aromatic Ring Count
0
cLogP
-8.9
TPSA
353.11
Fraction CSP3
1.0
Chiral centers
19.0
Largest ring
6.0
QED
0.11
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Bacterial
antibiotic
30S ribosome
Phospholipase
CXCR4
Pathway
Anti-infection
Microbiology/virology
Metabolism
MOA
Antibiotic inhibitor
ribosome inhibitor
bacterial 30S ribosomal subunit inhibitor
Indication
first-aid antibiotic, hepatic encephalopathy (HE), intra-abdominal infections
Disease Area
infectious disease, gastroenterology
Therapeutic Class
Antibiotics
Source data

